GNI Group Ltd. (TYO:2160)
2,625.00
+45.00 (1.74%)
Jun 3, 2026, 3:30 PM JST
GNI Group Revenue
GNI Group had revenue of 5.53B JPY in the quarter ending March 31, 2026, with 3.86% growth. This brings the company's revenue in the last twelve months to 27.05B, up 17.67% year-over-year. In the year 2025, GNI Group had annual revenue of 26.84B with 13.68% growth.
Revenue (ttm)
27.05B
Revenue Growth
+17.67%
P/S Ratio
5.32
Revenue / Employee
27.32M
Employees
990
Market Cap
143.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.84B | 3.23B | 13.68% |
| Dec 31, 2024 | 23.61B | -2.40B | -9.22% |
| Dec 31, 2023 | 26.01B | 8.59B | 49.33% |
| Dec 31, 2022 | 17.42B | 4.73B | 37.26% |
| Dec 31, 2021 | 12.69B | 2.92B | 29.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takara Bio | 40.32B |
| Nxera Pharma | 34.23B |
| PeptiDream | 19.05B |
| Japan Tissue Engineering | 2.18B |
| AnGes | 908.00M |
| Cuorips | 212.00M |
| Healios K.K. | 74.00M |
| Renascience | 68.00M |